Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Investigation of EGFR and ALK mutation frequency and treatment results in advanced non-small cell lung cancer.

Journal of cancer research and therapeutics - 1 Apr 2023

Komurcuoglu Berna, Karakurt Gamze, Kaya Ozge O, Diniz Gulden, Kırbıyık Ozgür, Evkan Aysen, Yalnız Enver

Abstract excerpt

Aim: Lung cancer has opened a new era in cancer treatment by elucidating the tumor's molecular structure and identifying the targetable mutations. Identifying the targeted mutations in lung cancer constitutes one of the main steps of treatment planning. The frequency of EGFR (epidermal growth factor receptor gene) and ALK (anaplastic lymphoma kinase gene) mutations in non-small cell lung cancer (NSCLC) also...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anaplastic Lymphoma Kinase
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to In Situ Hybridization, Fluorescence

Share to Lung Neoplasms

Share to Mutation

Share to Mutation Rate

Source

Identifiers

PMID: 37147996
DOI: 10.4103/jcrt.JCRT_1766_20

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Investigation of EGFR and ALK mutation frequency and treatment results in advanced non-small cell lung cancer.PMID 37147996Read ↗

The prevalence and clinical significance of EGFR mutations in non-small cell lung cancer patients in Egypt: a screening study.Semantic proximity Read ↗

Prevalence of EGFR mutations in newly diagnosed locally advanced or metastatic non-small cell lung cancer Spanish patients and its association with histological subtypes and clinical features: The Spanish REASON study.Semantic proximity Read ↗

EGFR mutation status in Middle Eastern patients with non-squamous non-small cell lung carcinoma: A single institution experience.Semantic proximity Read ↗

Prevalence of Epidermal Growth Factor Receptor Mutations in Patients with Non-Small Cell Lung Cancer in Turkish Population.Semantic proximity Read ↗

EGFR and KRAS mutations in Turkish non-small cell lung cancer patients: a pilot study.Semantic proximity Read ↗

EGFR mutations in non-small cell lung cancer: an audit from West China Hospital.Semantic proximity Read ↗

EGFR mutation status in Tunisian non-small-cell lung cancer patients evaluated by mutation-specific immunohistochemistry.Semantic proximity Read ↗

Relationship between epidermal growth factor receptor gene mutations and clinicopathological features in patients with non-small cell lung cancer in western Turkey.Semantic proximity Read ↗

Regional distribution of genetic mutation in lung cancer in Turkey (REDIGMA).Semantic proximity Read ↗

EGFR MUTATIONS IN NON-SMALL CELL LUNG CANCER: LOCAL EPIDEMIOLOGY AND CLINICAL IMPORTANCE.Semantic proximity Read ↗

Treatment of advanced non-small-cell lung cancer with epidermal growth factor receptor (EGFR) mutation or ALK gene rearrangement: results of an international expert panel meeting of the Italian Association of Thoracic Oncology.Semantic proximity Read ↗

Survival difference according to mutation status in a prospective cohort study of Australian patients with metastatic non-small-cell lung carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.